Distribution of α1-antitrypsin PI S and PI Z frequencies in countries outside Europe: A meta-analysis

Clinical Genetics

Volumn 60, Issue 6, 2001, Pages 431-441

  Blanco, I ^a   Bustillo, E F ^b   Rodriguez, M C ^b  

^a HOSPITAL VALLE DEL NALÓN   (Spain)

^b Instituto Nacional de Silicosis   (Spain)

Author keywords

1 antitrypsin; Geographical distribution; Pl types; Population studies

Indexed keywords

ALPHA 1 ANTITRYPSIN; CROSS REACTING ANTIBODY; CROSS REACTING ANTIGEN; POLYACRYLAMIDE GEL; ALPHA 1 ANTITRYPSIN, S VARIANT; ALPHA 1-ANTITRYPSIN, S VARIANT; SERPINA1 PROTEIN, HUMAN;

ARTICLE; CONSULTATION; CONTROLLED STUDY; CROSS REACTION; EUROPE; GENE FREQUENCY; GENETIC SCREENING; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; ISOELECTRIC FOCUSING; META ANALYSIS; OUTCOMES RESEARCH; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; AFGHANISTAN; AFRICA; AUSTRALIA; CANADA; CHINA; CLINICAL TRIAL; GENETICS; JAPAN; JORDAN; KOREA; MALAYSIA; NEW ZEALAND; UNITED STATES;

AFGHANISTAN; AFRICA; ALPHA 1-ANTITRYPSIN; AUSTRALIA; CANADA; CHINA; GENE FREQUENCY; HUMANS; JAPAN; JORDAN; KOREA; MALAYSIA; NEW ZEALAND; UNITED STATES;

EID: 0035544321     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600605.x     Document Type: Article

References (100)

1. Complete sequence of the cDNA for human α1-antitrypsin and the gene for the S variant
2. Liver injury in alpha-1-antitrypsin deficiency
3. Molecular basis of alpha-1-antitrypsin deficiency
4. α1-antitrypsin deficiency
5. Characterisation of the gene and protein of the common α-1-antitrypsin normal M2 allele
6. Characterisation of the coding sequence of the normal M4 α-1-antitrypsin gene
7. α1-antitrypsin deficiency in Europe: Geographical distribution of PI types S and Z
8. α1-antitrypsin Pi phenotypes S and Z in Spain: An analysis of the published surveys
9. Alpha-1-antitrypsin deficiency: Epidemiology and prevalence
10. Alpha-1-antitrypsin PI phenotypes S and Z in Europe: An analysis of the published surveys
11. Alpha-1-antitrypsin deficient variant Siiyama (Ser 53[TCC] to Phe 53[TTC]) is prevalent in Japan. Status of alpha-1-antitrypsin deficiency in Japan
12. Alpha-1-antitrypsin variants in New Zealand
13. Alpha-1-protease inhibitor phenotypes and serum concentrations in Thailand
14. Serum protein polymorphisms in four populations of Afghanistan
15. The Malaysian experience in the typing of genetic variants of alpha-1-antitrypsin
16. New phenotypes of serum alpha1-antirypsin in Japanese detected by gel slab isoelectric focusing
17. Alpha-1-antitrypsin phenotypes in a Nigerian population
18. Prevalence of alpha-1-antitrypsin Pi types among newborn infants of different ethnic backgrounds
19. State of alpha-1-antitrypsin deficiency in Japan
20. Alpha-1-antitrypsin Pi types in post-mortem blood
21. Liver disease associated with alpha-1-antitrypsin deficiency in childhood
22. Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industries
23. Alpha-1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community
24. Group-specific component, alpha1-antitrypsin and esterase D in Canadian Eskimos
25. Alpha-1-antitrypsin phenotypes in French Canadian newborns
26. Pi phenotypes in North America workers: Racial differences and comparisons with reported frequencies
27. Alpha-1-antitrypsin deficiency: Its effect on pulmonary function in Saskatchewan grain buyers
28. Increased mortality in the siblings of offspring of Pi type MS and MZ men from Saskatchewan
29. Alpha-1-antitrypsin phenotypes in Canadian Metis
30. Alpha-1-antitrypsin: Physiology, genetics, and pathology
31. Serum alpha-1-antitrypsin variants: Prevalence and clinical spirometry
32. The prevalence of alpha-1-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease
33. Antitrypsin gene frequencies in healthy people
34. Alpha1-antitrypsin and its deficiency: State of the art
35. Serum trypsin inhibitory capacity and Pi phenotypes. I. Methods and control values
36. Antitrypsine phenotypes in St Louis
37. A genetic-epidemiological study of chronic obstructive pulmonary disease. I. Study design and preliminary observations
38. Screening for alpha-1-antitrypsin deficiency
39. Racial distribution of alpha-1-antitrypsin variants among junior high school students
40. Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children
41. Relation of protease inhibitor phenotypes to obstructive lung disease in a community
42. Tucson epidemiologic study of obstructive lung diseases. i. Methodology and prevalence of disease
43. Neonatal screening for alpha-1-antitrypsin deficiency
44. Alpha-1-antitrypsin: Further genetic heterogeneity revealed by isoelectric focusing
45. Distribution of alpha-1-antitrypsin variants in a US white population
46. Alpha-1-antitrypsin deficiency: High prevalence in the St. Louis area determined by direct population screening
47. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks
48. Antitrypsin and chronic obstructive pulmonary disease among Japanese-American men
49. Molecular confirmation of alpha-1-antitrypsin genotypes in newborn dried blood specimens
50. Alpha-1-antitrypsin in four different ethnic groups of Mexico
51. PI locus (alpha-1-antitrypsin allelic frequencies in an Andean Venezuelan population
52. The distribution of blood, serum protein, and enzyme groups on Manus Island (Admiralty Islands, New Guinea)
53. Distribution of α1-antitrypsin (PI) phenotypes in chromosome abnormalities
54. Antiproteases and Down's syndrome in an Australian population
55. Haptoglobin distributions in Down's syndrome
56. The distributions of seven genetic polymorphisms in patients with Down's syndrome
57. Distribution of the six α1-antitrypsin (PI) subtypes from a sample of blood donors
58. Alpha-1-protease inhibitor phenotypes in Australia
59. Effects of the protease inhibitor (Pi) polymorphism on alpha-1-antitrypsin concentration and elastase inhibitory capacity in human serum
60. Alpha-1-antitrypsin (protease inhibitor) phenotypes and longevity
61. Allelic frequencies of plasma alpha-1-antitrypsin in Chinese
62. Geographical variability of alpha-1-antitrypsin alleles in China: A study on six Chinese populations
63. Alpha-1-protease inhibitor (PI) subtypes in seven populations of East Asia
64. Investigations on the population genetics of the alpha1-antitrypsin polymorphism
65. Alpha-1-antitrypsin (Pi) types in Korean and Chinese populations
66. Alpha1-antitrypsin variants in different racial groups in Malaysia
67. The distribution of serum protein and enzyme groups among Batak of Samosir Island (Sumatra, Indonesia)
68. Alpha-1-antitrypsin phenotype of children with liver diseases in Thailand
69. Electrophoretic variants of human serum alpha1-antitrypsin in Japan
70. Prevalence of α1-antitrypsin deficiency in Japan
71. Case report of familial α1-antitrypsin deficiency
72. Study of α1-antitrypsin deficiency in one family
73. Distribution of α1-antitrypsin phenotypes in Japanese: Description of Pi M subtypes by isoelectric focusing
74. Alpha-1-antitrypsin (PiM) subtypes in Japanese
75. Haptoglobin, group-specific component, transferrin and α1-antitrypsin subtypes and new variants in Japanese
76. PI (α1-antitrypsin) polymorphism in the Japanese: Confirmation of PI*M4 and description of new PI variants
77. Alpha-1-antitrypsin: Frequencies of PiM subtypes and serum concentration in the Japanese population
78. An alpha-1-antitrypsin deficiency allele PI*Siiyama found in a disputed paternity case
79. Genetic variants of serum alpha-1-antitrypsin
80. Serum Pi types in some European, American, Asian, and African populations
81. Hp, Gc, Cp, Tf, Bg, and Pi phenotypes in leprosy patients and healthy controls from West Bengal (India)
82. Study of some serum group systems in the Mahishyes and the Muslims I 24-Parganas District; West Bengal
83. The distribution of red cell enzyme and serum protein groups in a population of Davi (Pit River, West Iran)
84. Alpha-1-antitrypsin subtypes in the populations of Germany, Ecuador, Afghanistan, Cameroon, and Saudi-Arabia
85. Alpha-1-antitrypsin phenotypes in a population of Jordan
86. The laboratory diagnosis of alpha-1-antitrypsin deficiency
87. Investigations on the population genetics of the alpha-1-antitrypsin polymorphism
88. Acid starch gel electrophoresis for detection of α1-antitrypsin variants (Pi types): Outline of techniques employed currently
89. α1-Antitrypsin polymorphism of a Bantu population: Description of a new allele PiL
90. Quantitative study of alpha-1-antitrypsin in an ethnic group of Ivory Coast: The Abrons
91. Alpha-1-antitrypsin phenotypes in a group of newborn infants in Somalia
92. Reliable classification of six PiM subtypes by separator isoelectric focusing
93. Alpha-1-antitrypsin (Pi) phenotypes in a village population from the Gambia, West Africa. Evidence of a new variant occurring at a polymorphic frequency
94. Antitrypsin and Gc polymorphisms in some populations of Congo: An unusual, highly frequent mutants, PIS, in Bakete and Babenga
95. Genetic study of Tunisian Berbers. II. Alpha-1-antitrypsin (Pi) polymorphism: Report of a new allele (Pi Berber)
96. Alpha-1-antitrypsin genetic polymorphism in South Africa
97. Population genetics (Hardy-Weinberg equilibrium and factors affecting it)
98. Restriction enzyme Mae III for prenatal diagnosis of alpha-1-antitrypsin deficiency